Literature DB >> 33592203

Forebrain expression of serine racemase during postnatal development.

Oluwarotimi O Folorunso1, Theresa L Harvey2, Stephanie E Brown2, Cristina Cruz3, Ellie Shahbo3, Ismail Ajjawi3, Darrick T Balu4.   

Abstract

N-methyl-D-aspartate receptors (NMDARs) are important for synaptogenesis, synaptic maturation and refinement during the early postnatal weeks after birth. Defective synapse formation or refinement underlie cognitive and emotional abnormalities in various neurodevelopmental disorders (NDDs), including schizophrenia (Sz) and autism spectrum disorder (ASD). Serine racemase (SR) is a neuronal enzyme that produces D-serine, a co-agonist required for full NMDAR activation. NMDAR hypofunction as a result of genetic SR elimination and reduced synaptic availability of D-serine reduces neuronal dendritic arborization and spine density. In adult mouse brain, the expression of SR parallels that of NMDARs across forebrain regions including the striatum, amygdala, hippocampus, and medial prefrontal cortex (mPFC). However, there have yet to be studies providing a detailed characterization of the spatial and temporal expression of SR during early periods of synaptogenesis. Here, we examined the postnatal expression of SR in cortical and subcortical brain regions important for learning, memory and emotional regulation, during the first four weeks after birth. Using dual-antigen immunofluorescence, we demonstrate that the number of SR+ neurons steadily increases with postnatal age across the mPFC, amygdala, hippocampus and striatum. We also identified differences in the rate of SR protein induction both across and within brain regions. Analyzing existing human post-mortem brain in situ data, there was a similar developmental mRNA expression profile of SRR and GRIN1 (GluN1 subunit) from infancy through the first decade of life. Our findings further support a developmental role for D-serine mediated NMDAR activation regulating synaptogenesis and neural circuit refinement, which has important implications for the pathophysiology of Sz and other NDDs.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  D-serine; GRIN1; N-methyl-D-aspartate receptor (NMDAR); Schizophrenia; Serine racemase; Synaptogenesis

Mesh:

Substances:

Year:  2021        PMID: 33592203      PMCID: PMC8012237          DOI: 10.1016/j.neuint.2021.104990

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  65 in total

Review 1.  The integrative function of the basal ganglia in instrumental conditioning.

Authors:  Bernard W Balleine; Mimi Liljeholm; Sean B Ostlund
Journal:  Behav Brain Res       Date:  2008-11-05       Impact factor: 3.332

2.  Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists.

Authors:  Thomas Papouin; Laurent Ladépêche; Jérôme Ruel; Silvia Sacchi; Marilyne Labasque; Marwa Hanini; Laurent Groc; Loredano Pollegioni; Jean-Pierre Mothet; Stéphane H R Oliet
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

3.  Synaptic Proteome Alterations in the Primary Auditory Cortex of Individuals With Schizophrenia.

Authors:  Matthew L MacDonald; Megan Garver; Jason Newman; Zhe Sun; Joseph Kannarkat; Ryan Salisbury; Jill Glausier; Ying Ding; David A Lewis; Nathan Yates; Robert A Sweet
Journal:  JAMA Psychiatry       Date:  2020-01-01       Impact factor: 21.596

Review 4.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

5.  Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.

Authors:  William R Perlman; Maree J Webster; Joel E Kleinman; Cynthia Shannon Weickert
Journal:  Biol Psychiatry       Date:  2004-12-01       Impact factor: 13.382

6.  The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle.

Authors:  Samah Neame; Hazem Safory; Inna Radzishevsky; Ayelet Touitou; Francesco Marchesani; Marialaura Marchetti; Shai Kellner; Shai Berlin; Veronika N Foltyn; Simone Engelender; Jean-Marie Billard; Herman Wolosker
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

7.  Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study.

Authors:  S G Potkin; J A Turner; G G Brown; G McCarthy; D N Greve; G H Glover; D S Manoach; A Belger; M Diaz; C G Wible; J M Ford; D H Mathalon; R Gollub; J Lauriello; D O'Leary; T G M van Erp; A W Toga; A Preda; K O Lim
Journal:  Schizophr Bull       Date:  2008-11-27       Impact factor: 9.306

8.  An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia.

Authors:  Darrick T Balu; Yan Li; Shunsuke Takagi; Kendall Taylor Presti; Teniel S Ramikie; Jerri M Rook; Carrie K Jones; Craig W Lindsley; P Jeffrey Conn; Vadim Y Bolshakov; Joseph T Coyle
Journal:  Neuropsychopharmacology       Date:  2016-01-07       Impact factor: 7.853

9.  Serine racemase regulated by binding to stargazin and PSD-95: potential N-methyl-D-aspartate-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (NMDA-AMPA) glutamate neurotransmission cross-talk.

Authors:  Ting Martin Ma; Bindu D Paul; Chenglai Fu; Shaohui Hu; Heng Zhu; Seth Blackshaw; Herman Wolosker; Solomon H Snyder
Journal:  J Biol Chem       Date:  2014-08-27       Impact factor: 5.157

Review 10.  Astrocytes, neurons, synapses: a tripartite view on cortical circuit development.

Authors:  Isabella Farhy-Tselnicker; Nicola J Allen
Journal:  Neural Dev       Date:  2018-05-01       Impact factor: 3.842

View more
  1 in total

1.  Reduced d-serine levels drive enhanced non-ionotropic NMDA receptor signaling and destabilization of dendritic spines in a mouse model for studying schizophrenia.

Authors:  Deborah K Park; Samuel Petshow; Margarita Anisimova; Eden V Barragan; John A Gray; Ivar S Stein; Karen Zito
Journal:  Neurobiol Dis       Date:  2022-05-20       Impact factor: 7.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.